Canada markets open in 9 hours 7 minutes

Dyne Therapeutics, Inc. (DYN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
26.08+0.08 (+0.31%)
At close: 04:00PM EDT
26.08 0.00 (0.00%)
After hours: 04:04PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 2.28B
Enterprise Value 1.85B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)4.77
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -7.01

Trading Information

Stock Price History

Beta (5Y Monthly) 0.95
52-Week Change 390.62%
S&P500 52-Week Change 322.38%
52 Week High 330.27
52 Week Low 36.40
50-Day Moving Average 326.22
200-Day Moving Average 315.85

Share Statistics

Avg Vol (3 month) 31.29M
Avg Vol (10 day) 3821.02k
Shares Outstanding 587.38M
Implied Shares Outstanding 686.18M
Float 856.59M
% Held by Insiders 10.55%
% Held by Institutions 188.42%
Shares Short (Apr 15, 2024) 49.02M
Short Ratio (Apr 15, 2024) 46.62
Short % of Float (Apr 15, 2024) 412.87%
Short % of Shares Outstanding (Apr 15, 2024) 410.47%
Shares Short (prior month Mar 15, 2024) 46.82M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-40.98%
Return on Equity (ttm)-71.50%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -264.21M
Net Income Avi to Common (ttm)-257.4M
Diluted EPS (ttm)-3.98
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)453.55M
Total Cash Per Share (mrq)5.19
Total Debt (mrq)26.62M
Total Debt/Equity (mrq)5.57%
Current Ratio (mrq)21.83
Book Value Per Share (mrq)5.49

Cash Flow Statement

Operating Cash Flow (ttm)-219.79M
Levered Free Cash Flow (ttm)-152.87M